You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ZANTAC 150 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for ZANTAC 150
US Patents:0
Applicants:3
NDAs:4
Raw Ingredient (Bulk) Api Vendors: 117
Clinical Trials: 22
Patent Applications: 2,243
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in ZANTAC 150?ZANTAC 150 excipients list
DailyMed Link:ZANTAC 150 at DailyMed
Drug patent expirations by year for ZANTAC 150
Recent Clinical Trials for ZANTAC 150

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Spaulding Clinical Research LLCPhase 1
Food and Drug Administration (FDA)Phase 1
Dalhousie UniversityPhase 4

See all ZANTAC 150 clinical trials

US Patents and Regulatory Information for ZANTAC 150

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ZANTAC 150 ranitidine hydrochloride CAPSULE;ORAL 020095-001 Mar 8, 1994 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 021698-001 Aug 31, 2004 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride GRANULE, EFFERVESCENT;ORAL 020251-002 Mar 31, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020251-001 Mar 31, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZANTAC 150

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 018703-001 Jun 9, 1983 ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline ZANTAC 150 ranitidine hydrochloride CAPSULE;ORAL 020095-001 Mar 8, 1994 ⤷  Try a Trial ⤷  Try a Trial
Chattem Sanofi ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 021698-002 Mar 13, 2007 ⤷  Try a Trial ⤷  Try a Trial
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 018703-001 Jun 9, 1983 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.